HPS masthead
What's New?
. Fukushima Decontamination Report
. CRCPD & CDC Grants for Volunteer Corps
. America's Nuclear Future
. February Newsletter
. Boice Nominated President of NCRP
. February Journal
. February ORS
. Schauer Given the Butterfly Award from Image Gently
. Kase President's Report to IRPA
. IRPA13 Accepting Posters
Upcoming Events
. HPS Midyear - Issues in Waste Management
5-8 February 2012
Dallas, Texas
. NRC Regulatory Information Conference
NRC Regulatory Information Conference
13-15 March 2012
Rockville, Maryland
. NCRP Annual Meeting
12-13 March 2012
Washington, DC
. James E. Turner Memorial Symposium
Call for Abstracts
18-19 April 2012
Oak Ridge Associated Universities, Pollard Auditorium, Oak Ridge, Tennessee
. IRPA13
13-18 May 2012
Glasgow, Scotland
. Canadian Radiation Protection Association (CRPA) Annual Meeting
27-30 May 2012
Halifax, Nova Scotia
. ACS Undergrad Summer Schools
10 June- 20 July 2012
. Nuclear Regulatory Commission Meeting Webcasts
February 2012
Bethesda, Maryland
09 February 2012

Answer to Question #4507 Submitted to "Ask the Experts"

Category: Nuclear Medicine Patient Issues — Therapeutic Nuclear Medicine

The following question was answered by an expert in the appropriate field:

Q
If a patient has had his/her thyroid removed and is about to receive a follow-up dose of 100 mCi of 131I and is on dialysis three days a week, what precautions should be used? Will the dialysis be effective to rid the body of the iodine? How long after an iodine treatment should a facility wait to perform the dialysis?
A
There are a small number of dialysis patients who have been treated with 131NaI for thyroid cancer. In my limited experience involving just a couple of cases, I decreased the administered activity to the patient. Instead of a biological half-life of about 12 hours as it is in patients who are allowed to become hypothyroid by stopping synthroid therapy, the biological half-life is closer to the frequency between dialysis treatments, e.g., one day if dialysis is used daily. Also, the bone marrow dose is much higher than usual. I started dialysis 24 hours after administration, and continued it daily for several days. The first dialysis took out about half the radioiodine, and the next couple of dialysis sessions took out about one-third of the remaining radioiodine each time. Before I did my first case, I did internal dosimetry assuming daily dialysis and a half-life of about 24 hours, and used about half the administered activity I would have normally used if the patient had normal renal function. If a patient's dialysis is every other day, then the biological half-life is approximately twice as long and that has to be taken into consideration, i.e., by decreasing the administered activity will be by more than a factor of two.

I am unaware of any "standard of medical practice" associated with this procedure. But in my opinion, a physician should either perform the dosimetry calculations, or get a good medical physicist to do so, before determining the appropriate administered activity to use.

Carol S. Marcus, PhD, MD
Answer posted on 16 May 2005. The information and material posted on this website is intended as general reference information only. Specific facts and circumstances may alter the concepts and applications of materials and information described herein. The information provided is not a substitute for professional advice and should not be relied upon in the absence of such professional advice specific to whatever facts and circumstances are presented in any given situation. Answers are correct at the time they are posted on the Website. Be advised that over time, some requirements could change, new data could be made available, or Internet links could change. For answers that have been posted for several months or longer, please check the current status of the posted information prior to using the responses for specific applications.
image
image
Home Affiliates Ask the Experts Radiation Terms Employment Meetings